期刊文献+

C型利钠肽在髂动脉球囊成形术后再狭窄发生中的作用

Effect of C-type natriuretic peptide on post-PTA restenosis in iliac artery of atherosclerotic rabbit model
下载PDF
导出
摘要 目的:探讨C型利钠肽(C-type natriuretic peptide,CNP)在髂动脉球囊成形术后再狭窄发生中的作用。方法:构建兔髂动脉粥样硬化模型,将动物分为球囊成形术(Percutaneous transluminal angioplasty,PTA)组和假手术组,观察PTA术后CNP表达变化;将CNP基因转染髂动脉,观察CNP基因过表达对PTA术后再狭窄的影响。结果:PTA术后2、4周RT-PCR、荧光定量RT-PCR、免疫组化、Western blot检测显示CNP表达明显降低;PTA术后8周CNP表达无明显差异。CNP基因过表达组内膜增生程度、内膜/中膜比及血管狭窄率明显降低。结论:CNP表达减少可能是PTA术后再狭窄发生原因之一,增加CNP表达可一定程度预防再狭窄发生。 Objective:To discuss the potential role of C-type natriuretic peptide(CNP) on occurrence of vascular restenosis after percutaneous transluminal angioplasty(PTA).Methods:CNP expression was detected with RT-PCR,real-time quantitative RT-PCR,Western blot and immunohistochemistry after PTA in iliac artery in rabbit model of atherosclerosis.Reconstructed plasmid pcDNA3.1(+)/hCNP was transfected with polyethylenimine in iliac artery to investigate the effect of CNP over-expression on post-PTA restenosis.Results:CNP expression decreased markedly 2 and 4 weeks after PTA.The relative levels of CNP mRNA expression revealed with RT-PCR were 0.38±0.06 vs 0.98±0.15 and 0.43±0.05 vs 1.01±0.12(P〈0.001).With real-time quantitative RT-PCR,Ct value ratios were 2.06±0.17 vs 1.27±0.10 and 2.10±0.11 vs 1.23±0.10(P〈0.001).The relative levels of CNP protein expression detected with Western blot were 0.15±0.03 vs 0.31±0.06 and 0.13±0.04 vs 0.30±0.05(P〈0.001).A lighter dyeing was identified in PTA group in both 2 weeks and 4 weeks with immunohistochemistry.CNP mRNA and protein expressions were not different on 8-week spot between PTA and non-PTA groups.Hyperplasia and restenosis rate after PTA declined significantly in CNP over-expression group compared with non-transfected one(0.29±0.07 vs 0.76±0.06;0.31±0.02 vs 0.57±0.05,P〈0.001).Conclusion:CNP down-expression may be one of the reasons to induce post-PTA restenosis.CNP gene transfection is potential to prevent vascular restenosis.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2011年第10期1176-1179,共4页 Journal of Chongqing Medical University
基金 国家自然科学基金资助项目(编号:30860276) 云南省应用基础研究计划资助项目(编号:2007M272) 云南省科技厅-昆明医学院联合专项基金资助项目(编号:2008CD042)
关键词 C型利钠肽 球囊成形术 再狭窄 C-type natriuretic peptide percutaneous transluminal angioplasty restenosis
  • 相关文献

参考文献16

  • 1Schiele T M,Krotz F,Klauss V.Vascular restenosis-striving for ther-apy[J].Expert Opin Pharmacother,2004,5(11):2221-2232.
  • 2Tsigkas G G,Karantalis V,Hahalis G,et al.Stent restenosis,patho-physiology and treatment options:a 2010 update[J].Hellenic J Cardiol,2011,52(2):149-157.
  • 3Cooke J P,Ghebremariam Y T.Dietary nitrate,nitric oxide,andrestenosis[J].J Clin Invest,2011,121(4):1258-1260.
  • 4Lumsden N G,Khambata R S,Hobbs A J.C-type natriuretic pep-tide(CNP):cardiovascular roles and potential as a therapeutic target[J].Curr Pharm Des,2010,16(37):4080-4088.
  • 5Federico C.Natriuretic Peptide system and cardiovascular disease[J].Heart Views,2010,11(1):10-15.
  • 6肖乐,赵渝,时德.人C型利钠肽基因的克隆及其真核表达载体的构建[J].重庆医科大学学报,2006,31(4):474-477. 被引量:3
  • 7Schgger H,Jagow G.Tricine-sodium dodecyl sulfate-polyacrylamidegel electrophoresis for the separation of proteins in the range from 1 to100 kDa[J].Anal Biochem,1987,166(2):368-379.
  • 8Nishikimi T,Kuwahara K,Nakao K.Current biochemistry,molecu-lar biology,and clinical relevance of natriuretic peptides[J].J Cardiol,2011,57(2):131-140.
  • 9Edwards G,Feletou M,Weston A H.Endothelium-derived hyperpo-larizing fact-ors and associated pathways:a synopsis[J].Pflugers Arch,2010,459(6):863-879.
  • 10Eshtehardi P,Cook S,Wandel S,et al.Impact of arterial injury onneointimal hyperplasia after implantation of drug-eluting stents incoronary arteries:an intravascular ultrasound study[J].Euro Intervention,2010,6(4):467-474.

二级参考文献39

  • 1杨宗城.严重烧伤治疗进展与展望[J].中华烧伤杂志,2006,22(3):237-240. 被引量:29
  • 2肖乐,赵渝,时德.人C型利钠肽基因的克隆及其真核表达载体的构建[J].重庆医科大学学报,2006,31(4):474-477. 被引量:3
  • 3Segawa K, Minami K, Jimi N, Nakashima Y, Shigematsu A. C-type natriuretic peptide inhibits rat mesangial cell proliferation by a phosphorylation-dependent mechanism [J]. Nau Schm Arch Pharmacol, 1998, 357 (1): 70-76
  • 4Stadius ML, Gown AM, Kemoff R, Collins CL. Cell proliferation after balloon injury of iliac arteries in the cholesterol-fed New Zealand white rabbit [ J ]. Arteroscler Thromb, 1994, 14 (5) : 727-733
  • 5Ikeda M, Kohno M, Yasunari K, Yokokawa K, Horio T, Ueda M, et al. Natriuretic peptide family as a novel antimigration factor of vascular smooth muscle cells[J]. Artetioscler Thromb Vasc Biol, 1997, 17(4): 731-736
  • 6Gibbons GH, Dzau VJ. Molecular therapies for vascular diseases [ J ]. Science, 1996, 272 (5262): 689-693
  • 7Yamashita J, Itoh H, Ogawa Y, Tamura N, Takaya K, Igaki T, et al. Opposite regulation of Gax homeobox expression by angiotensin Ⅱ and C-type natriuretic peptide [J]. Hypertension, 1997, 29 (1 Pt 2): 381-387
  • 8Doi K, Itoh H, Ikeda T, Hosoda K, Ogawa Y, Igaki T, et al. Adenovirusmediated gene transfer of C-type natriuretic peptide causes G1 growth inhibition of cultured vascular smooth muscle cells [ J]. Biochem Biophys Res Commun,1997, 239 (3): 889-894
  • 9Cascells W, Engler D, Willerson JT. Mechanisms d restenosis [J]. Tex Heart Inst J, 1994, 21 (1): 68-77
  • 10Barr CS, Rhodes P, Struthers AD. C-type natriuetic peptide [J]. peptides,1996, 17 (7) : 1 243-251

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部